Aclaris Therapeutics, Inc. (ACRS) Balance Sheet
As of 2026-06-30 (10-Q), Aclaris Therapeutics, Inc. (ACRS) reported total assets of $179.7M, total liabilities of $55.1M and shareholders' equity of $124.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $19.2M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ACRSAclaris Therapeutics, Inc.Follow ACRS — free
—
Price chart with a free account
- Market cap
- 552.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9.9 | 30.2 | 20.2 | 57.0 | 35.9 | 22.1 | 27.3 | 45.3 | 39.9 | 24.6 | 20.0 | 19.2 | |
| Short-term investments | 75.0 | 107.1 | 173.7 | 111.0 | 39.1 | 32.1 | 164.1 | 172.3 | 79.2 | 89.0 | 70.8 | 72.4 | |
| Receivables | — | — | 0.5 | 0.6 | 0.7 | 0.8 | 0.6 | 0.5 | 0.3 | 0.3 | — | — | |
| Inventory | — | — | — | 0.8 | 0.0 | — | — | — | — | — | — | — | |
| Current assets | 86.5 | 138.6 | 200.2 | 179.5 | 83.8 | 57.5 | 205.0 | 231.6 | 128.9 | 126.0 | 96.3 | 97.8 | |
| Total assets | 94.1 | 176.1 | 243.5 | 275.6 | 98.3 | 70.8 | 251.2 | 254.6 | 197.4 | 220.3 | 160.5 | 179.7 | |
| Current liabilities | 1.6 | 6.2 | 12.8 | 27.3 | 22.4 | 14.9 | 22.9 | 21.9 | 31.0 | 31.6 | 28.6 | 28.2 | |
| Long-term debt | — | — | — | 29.9 | — | 10.7 | — | — | — | — | — | — | |
| Total liabilities | 1.6 | 6.6 | 18.2 | 60.4 | 28.4 | 33.1 | 53.9 | 57.0 | 40.2 | 64.8 | 57.4 | 55.1 | |
| Shareholders' equity | 92.5 | 169.5 | 225.3 | 215.1 | 69.9 | 37.7 | 197.3 | 197.6 | 157.2 | 155.6 | 103.1 | 124.6 |
USD millions · SEC XBRL
Aclaris Therapeutics, Inc. — questions
- How much cash does Aclaris Therapeutics, Inc. have?
- $19.2M in cash and cash equivalents as of 2026-06-30.
- What are Aclaris Therapeutics, Inc.'s total assets?
- $179.7M as of 2026-06-30.
- What is Aclaris Therapeutics, Inc.'s shareholders' equity?
- $124.6M as of 2026-06-30.
Every figure on this page comes from Aclaris Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.